Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cardiovascular Dysfunction in Multiple Sclerosis.
Estrogen-mediated protection of experimental autoimmune encephalomyelitis: Lessons from the dissection of estrogen receptor-signaling in vivo.
Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions.
Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.
A urological challenge: Voiding dysfunction in multiple sclerosis.
Multiple sclerosis influences the precision of the ankle plantarflexon muscular force production.
Dendritic cells in brain diseases.
Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs.
Bilateral claw hand: An uncommon presentation of regional Guillain-Barré syndrome.
Anatomical and functional retinal changes in multiple sclerosis.
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.
MS Trust critical of guidance on multiple sclerosis.
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?
Auditory function in children with Charcot-Marie-Tooth disease.
Multiple sclerosis: Worrying data on excess mortality and comorbidity in MS.
Subgroup analysis in MS trials.
Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography.
Obstructive Sleep Apnea is an Under-Recognized and Consequential Morbidity in Multiple Sclerosis.
Microglia-blood vessel interactions: a double-edged sword in brain pathologies.
Cortical plasticity predicts recovery from relapse in multiple sclerosis.
IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties.
Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.
Sodium Correction Practice and Clinical Outcomes in Profound Hyponatremia.
Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis.
The Effect of Neural Lesion Type on Botulinum Toxin Dosage: A Retrospective Chart Review.
Pages
« first
‹ previous
…
634
635
636
637
638
639
640
641
642
…
next ›
last »